首页> 外文期刊>Expert opinion on therapeutic targets >Interleukin-6 and new strategies for the treatment of cancer, hyperproliferative diseases and paraneoplastic syndromes.
【24h】

Interleukin-6 and new strategies for the treatment of cancer, hyperproliferative diseases and paraneoplastic syndromes.

机译:白细胞介素6和治疗癌症,过度增殖性疾病和副肿瘤综合症的新策略。

获取原文
获取原文并翻译 | 示例
           

摘要

Interleukin-6 (IL-6) is a pleiomorphic cytokine whose growth factor properties play an important role in the development and progression of many types of cancer. IL-6 is produced in response to a variety of stimuli, and is required for the development of T and B lymphocytes to effector cells. In certain neoplasias, such as multiple myeloma, IL-6 is both produced and required for survival by the cancer cell itself. In other neoplasias, IL-6 may come from tissue surrounding the tumour. Thus, therapeutic strategies aimed at inhibiting the production, expression or action of IL-6 would be quite beneficial in the treatment of cancer. Moreover, IL-6 is a pathophysiological factor in several hyperproliferative diseases and the paraneoplastic syndromes that often accompany cancer, such as cachexia and osteoporosis; thus, anti-IL-6 therapy would be useful in treating these entities as well. This expert opinion acquaints the reader with IL-6, its physiological responses, the cancer types with which it is associated, and discusses the current state of therapy aimed at inhibiting it.
机译:白介素-6(IL-6)是一种多形细胞因子,其生长因子特性在多种类型的癌症的发生和发展中起着重要的作用。 IL-6是响应多种刺激而产生的,是T和B淋巴细胞向效应细胞发育所必需的。在某些瘤形成中,例如多发性骨髓瘤,癌细胞自身既产生IL-6又需要IL-6生存。在其他肿瘤中,IL-6可能来自肿瘤周围的组织。因此,旨在抑制IL-6的产生,表达或作用的治疗策略在癌症的治疗中将是非常有益的。此外,IL-6是多种恶性增生性疾病和恶性肿瘤常伴随癌症的病理生理因素,例如恶病质和骨质疏松症。因此,抗IL-6疗法也将在治疗这些实体中有用。该专家意见使读者熟悉IL-6,其生理反应,与之相关的癌症类型,并讨论了旨在抑制其的当前治疗状态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号